Clincosm LogoSign in Get a demo

carcinoma in situ

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Carcinoma in Situ Trial in Kannur (Triage of clinical breast examination positive women using handheld ultrasound

Recruiting
  • Breast Cancer
  • Carcinoma in Situ
  • Triage of clinical breast examination positive women using handheld ultrasound by non-radiologists.
  • Kannur, India
    Malabar Cancer Care Society Kannur
Sep 28, 2023

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Carcinoma In Situ, Current Smoker, Malignant Tumor Trial in United States (Behavioral, Psychological or Informational

Active, not recruiting
  • Carcinoma In Situ
  • +4 more
  • Behavioral, Psychological or Informational Intervention
  • +4 more
  • Anchorage, Alaska
  • +41 more
Jan 12, 2023

Cervical Intraepithelial Neoplasia Grade 2/3, Tumor Cervix, Carcinoma in Situ Trial in Milan (Self-Collecting Devices, In Vitro

Completed
  • Cervical Intraepithelial Neoplasia Grade 2/3
  • +5 more
  • Self-Collecting Devices
  • In Vitro Diagnostic Assays
  • Dublin, Ireland
  • +5 more
Jan 5, 2023

Anal Dysplasia, Carcinoma in Situ Trial in Philadelphia (Gliolan, Vitamin D3 cholecalciferol), Photodynamic Therpay)

Withdrawn
  • Anal Dysplasia
  • Carcinoma in Situ
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 21, 2022

Project: Every Child for Younger Patients With Cancer

Recruiting
  • Carcinoma In Situ
  • +10 more
  • Cytology Specimen Collection Procedure
  • Medical Chart Review
  • Birmingham, Alabama
  • +240 more
Oct 19, 2022

Ovarian Epithelial Cancer, Carcinoma in Situ, Ovarian Cancer Trial in Worldwide (Lavage of the Cavum uteri and proximal

Completed
  • Ovarian Epithelial Cancer
  • +2 more
  • Lavage of the Cavum uteri and proximal Fallopian tubes, performed in the luteal phase of the female cycle
  • Graz, Austria
  • +13 more
Sep 1, 2022

Ovarian Epithelial Cancer, Carcinoma in Situ, Ovarian Cancer Trial in Worldwide (Speiser-catheter for uterine and tubal lavage)

Completed
  • Ovarian Epithelial Cancer
  • +2 more
  • Speiser-catheter for uterine and tubal lavage
  • Graz, Austria
  • +8 more
Sep 1, 2022

HNSCC, Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Tucson (Avmacol®)

Completed
  • HNSCC
  • +7 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Jun 17, 2021

Transitional Cell Carcinoma, Bladder Cancer, Carcinoma in Situ Trial in United States (CG0070 Adenovirus Vector, Control Arm:

Terminated
  • Transitional Cell Carcinoma
  • +3 more
  • CG0070 Adenovirus Vector
  • Control Arm: Quadruple Choice
  • Phoenix, Arizona
  • +6 more
Apr 12, 2021

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Head and Neck Carcinoma Trial in Pittsburgh (Avmacol)

Completed
  • Head and Neck Cancer
  • +8 more
  • Avmacol
  • Pittsburgh, Pennsylvania
  • +1 more
Apr 7, 2021

Carcinoma in Situ, Transitional Cell Carcinoma, Non-muscle Invasive Bladder Cancer Trial in United States (VALSTAR - Maintenance

Terminated
Has Results
  • Carcinoma in Situ
  • +2 more
  • VALSTAR - Maintenance Therapy
  • No Maintenance treatment ( Standard of Care)
  • Phoenix, Arizona
  • +5 more
Sep 7, 2017

Breast Cancer, Carcinoma in Situ Trial in Copenhagen (Radioactive seed localization (RSL), Wire-guided localization (WGL))

Completed
  • Breast Cancer
  • Carcinoma in Situ
  • Radioactive seed localization (RSL)
  • Wire-guided localization (WGL)
  • Copenhagen, Østerbro, Denmark
    Rigshospitalet (Copenhagen University Hospital)
Aug 9, 2017

Chronic Inflammation of Hypopharynx, Hoarseness, Macroscopic Laryngeal Lesions Trial in Ostrava (NBI endoscopy)

Completed
  • Chronic Inflammation of Hypopharynx
  • +7 more
  • NBI endoscopy
  • Ostrava, Moravian-Silesian Region, Czech Republic
    University Hospital Ostrava
Sep 7, 2016

Carcinoma in Situ, Bladder Cancer Trial in United States (Valrubicin, 800 mg)

Completed
  • Carcinoma in Situ
  • Bladder Cancer
  • Valrubicin, 800 mg
  • Alabaster, Alabama
  • +38 more
Jun 10, 2015

Carcinoma in Situ, Non Muscle Invasive Bladder Cancer Trial in United States (TMX-101)

Completed
  • Carcinoma in Situ
  • Non Muscle Invasive Bladder Cancer
  • Phoenix, Arizona
  • +3 more
Feb 9, 2015